Dec 10, 2018· Association For Accessible Medicines (AAM)· USTR-2018-0035-0037
In response to the above-referenced notice, the Association for Affordable Medicine (AAM) hereby submits its request to testify as well as attached written comments in preparation for the negotiation of a U.S.-European Union (EU) Trade Agreement. AAM requests the opportunity to provide testimony at the December 14, 2018, hearing. The witness will be: Jeffrey K. Francer Senior Vice President & General Counsel Association for Accessible Medicines 601 New Jersey Ave. NW, Suite 850 Washington, DC 20001 Tel: 202-249-7128